HK1131400A1 - Process for the purification of fc-containing proteins - Google Patents

Process for the purification of fc-containing proteins

Info

Publication number
HK1131400A1
HK1131400A1 HK09111377.1A HK09111377A HK1131400A1 HK 1131400 A1 HK1131400 A1 HK 1131400A1 HK 09111377 A HK09111377 A HK 09111377A HK 1131400 A1 HK1131400 A1 HK 1131400A1
Authority
HK
Hong Kong
Prior art keywords
purification
containing proteins
proteins
Prior art date
Application number
HK09111377.1A
Other languages
English (en)
Inventor
Alex Eon-Duval
Alain Lamproye
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38610939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1131400(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of HK1131400A1 publication Critical patent/HK1131400A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK09111377.1A 2006-08-28 2009-12-03 Process for the purification of fc-containing proteins HK1131400A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119611 2006-08-28
US84254206P 2006-09-06 2006-09-06
PCT/EP2007/058887 WO2008025748A1 (en) 2006-08-28 2007-08-27 Process for the purification of fc-containing proteins

Publications (1)

Publication Number Publication Date
HK1131400A1 true HK1131400A1 (en) 2010-01-22

Family

ID=38610939

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09111377.1A HK1131400A1 (en) 2006-08-28 2009-12-03 Process for the purification of fc-containing proteins

Country Status (21)

Country Link
US (1) US8513393B2 (pl)
EP (1) EP2061803B2 (pl)
JP (1) JP2010501623A (pl)
KR (1) KR101770312B1 (pl)
AR (1) AR062570A1 (pl)
AU (1) AU2007291283B2 (pl)
CA (1) CA2661748C (pl)
DK (1) DK2061803T4 (pl)
EA (1) EA017152B1 (pl)
ES (1) ES2755386T5 (pl)
FI (1) FI2061803T4 (pl)
HK (1) HK1131400A1 (pl)
HU (1) HUE045898T2 (pl)
IL (1) IL197220A (pl)
LT (1) LT2061803T (pl)
MX (1) MX2009002014A (pl)
PL (1) PL2061803T5 (pl)
PT (1) PT2061803T (pl)
SI (1) SI2061803T2 (pl)
UA (1) UA99262C2 (pl)
WO (1) WO2008025748A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1969007T4 (pl) 2005-12-20 2014-04-30 Bristol Myers Squibb Co Kompozycje i sposoby wytwarzania kompozycji
AR058568A1 (es) 2005-12-20 2008-02-13 Bristol Myers Squibb Co Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
AU2007291283B2 (en) † 2006-08-28 2012-09-20 Ares Trading S.A. Process for the purification of Fc-containing proteins
HUE037409T2 (hu) * 2007-10-30 2018-08-28 Genentech Inc Antitest-tisztítás kationcserés kromatográfiával
US9109010B2 (en) * 2008-10-20 2015-08-18 Abbvie Inc. Viral inactivation during purification of antibodies cross reference to related applications
TW201030016A (en) * 2008-10-20 2010-08-16 Abbott Lab Antibodies that bind to IL-18 and methods of purifying the same
WO2010141039A1 (en) * 2008-10-20 2010-12-09 Abbott Laboratories Isolation and purification of antibodies using protein a affinity chromatography
EP2346898A2 (en) * 2008-10-20 2011-07-27 Abbott Laboratories Antibodies that bind to il-12 and methods of purifying the same
EP2462157B1 (en) * 2009-08-07 2020-06-17 EMD Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
KR101858266B1 (ko) 2009-12-18 2018-05-15 노파르티스 아게 친화성 크로마토그래피를 위한 세척용액 및 방법
CA2787009C (en) 2010-01-15 2018-04-03 Bio-Rad Laboratories, Inc. Surface neutralization of apatite
US8895707B2 (en) * 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
JP5798307B2 (ja) * 2010-09-03 2015-10-21 国立大学法人名古屋大学 グロボトリアオシルセラミドを特異的に認識するモノクローナル抗体及びその作製法
MX357821B (es) 2010-12-21 2018-07-25 Hoffmann La Roche Preparación de anticuerpo enriquecida con isoforma y método para obtenerla.
WO2012106449A1 (en) 2011-02-02 2012-08-09 Bio-Rad Laboratories, Inc. Apatite surface neutralization with alkali solutions
BR112013024933A2 (pt) 2011-03-29 2016-09-06 Glaxosmithkline Llc sistema tampão para purificação de proteínas
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
EP2855501B1 (en) 2012-05-30 2018-04-25 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
CN106536565A (zh) * 2014-06-13 2017-03-22 鲁宾有限公司 一种用于纯化TNFR‑Fc融合蛋白的方法
WO2015200278A1 (en) 2014-06-23 2015-12-30 Bio-Rad Laboratories, Inc. Apatite in-situ restoration
US9802822B2 (en) 2014-06-23 2017-10-31 Bio-Rad Laboratories, Inc. Apatite pretreatment
ES2733298T3 (es) * 2014-07-18 2019-11-28 Sandoz Ag Cuantificación de TNFR2:Fc plegado erróneamente
BR112017018365A2 (pt) * 2015-03-13 2018-04-10 Bristol-Myers Squibb Company uso de lavagens alcalinas durante cromatografia para remoção de impurezas
KR20230029621A (ko) 2020-05-08 2023-03-03 알파인 이뮨 사이언시즈, 인코포레이티드 T 세포 억제 단백질을 포함하거나 포함하지 않는 april 및 baff 억제 면역조절 단백질 및 이의 사용 방법

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003553A1 (en) 1989-09-05 1991-03-21 Immunex Corporation TUMOR NECROSIS FACTOR-α AND -β RECEPTORS
US5447851B1 (en) * 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
JPH07504203A (ja) 1992-09-15 1995-05-11 イミュネックス・コーポレーション 腫瘍壊死因子アンタゴニストを用いるｔｎｆ−依存性炎症の治療方法
ES2129076T5 (es) * 1993-12-27 2003-05-16 Zlb Bioplasma Ag Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene.
US6406901B1 (en) * 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
IL122305A0 (en) 1995-06-08 1998-04-05 Immunex Corp Tace polypeptide its production and its use
US5969102A (en) 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
IL121900A (en) † 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
CN101333244B (zh) † 1998-05-06 2013-12-18 基因技术股份有限公司 用离子交换层析纯化蛋白质
CA2333747C (en) 1998-06-01 2008-02-19 Genentech, Inc. Separation of protein monomers by use of ion-exchange chromatography
PT1084147E (pt) † 1998-06-09 2005-01-31 Statens Seruminstitut Processo para producao de imunoglobulinas para administracao intravenosa e outros produtos de imunoglobulina
JP5021117B2 (ja) 1999-01-07 2012-09-05 ザイモジェネティクス， インコーポレイテッド 可溶性エフェクターＢＲ４３ｘ２およびその使用方法
DE19955558C2 (de) 1999-11-18 2003-03-20 Stefan Kochanek Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren
DE60128216T2 (de) * 2000-05-12 2008-01-10 Amgen Inc., Thousand Oaks Polypeptide zum Hemmen der April-vermittelten Proliferation von B- und T- Zellen
ATE542545T1 (de) * 2001-05-24 2012-02-15 Zymogenetics Inc Taci-immunoglobulin-fusionsproteine
KR20040023630A (ko) † 2001-06-26 2004-03-18 아브게닉스, 인크. Ｏｐｇｌ에 결합하는 항체
DE60231651D1 (de) 2001-12-21 2009-04-30 Immunex Corp Proteinreinigungsverfahren
JP4319979B2 (ja) † 2002-04-26 2009-08-26 ジェネンテック・インコーポレーテッド タンパク質の非アフィニティ精製
CN100522989C (zh) 2002-09-11 2009-08-05 中外制药株式会社 纯化蛋白质的方法
ES2629602T5 (es) † 2002-09-11 2021-06-08 Genentech Inc Purificación de proteínas
DK1601697T3 (da) * 2003-02-28 2007-10-01 Lonza Biologics Plc Oprensning af antistof ved protein A- og ionbytningskromatografi
EP1614693A4 (en) * 2003-03-31 2006-07-19 Kirin Brewery PURIFICATION OF A HUMAN MONOCLONAL ANTIBODY AND A HUMAN POLYCLONAL ANTIBODY
TWI353991B (en) * 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
CN1898266B (zh) * 2003-10-27 2011-09-21 惠氏公司 使用羟磷灰石层析除去高分子量聚集体
ES2383300T3 (es) 2003-11-13 2012-06-20 Hanmi Holdings Co., Ltd Fragmento Fc de IgG para un vehículo de fármacos y procedimiento para su preparación
CN1946739A (zh) * 2004-04-14 2007-04-11 豪夫迈－罗氏公司 纯化的白细胞介素－15/Fc融合蛋白及其制备
PT1869065T (pt) 2005-03-11 2020-06-18 Wyeth Llc Método de cromatografia de partição fraca
CA2604877A1 (en) * 2005-04-11 2006-10-19 J.P. Sercel Associates Inc. Protein purification
EP1896506B1 (en) * 2005-06-17 2013-01-02 Janssen Alzheimer Immunotherapy Methods of purifying anti a beta antibodies
EP2069387A4 (en) † 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
AU2007291283B2 (en) † 2006-08-28 2012-09-20 Ares Trading S.A. Process for the purification of Fc-containing proteins
WO2008087184A2 (en) * 2007-01-17 2008-07-24 Merck Serono S.A. Process for the purification of fc-containing proteins

Also Published As

Publication number Publication date
JP2010501623A (ja) 2010-01-21
EA017152B1 (ru) 2012-10-30
PL2061803T3 (pl) 2020-02-28
DK2061803T3 (da) 2019-11-18
CA2661748A1 (en) 2008-03-06
EP2061803A1 (en) 2009-05-27
KR101770312B1 (ko) 2017-08-22
US20100190961A1 (en) 2010-07-29
AU2007291283B2 (en) 2012-09-20
SI2061803T2 (sl) 2023-01-31
FI2061803T4 (fi) 2023-03-14
HUE045898T2 (hu) 2020-01-28
LT2061803T (lt) 2019-11-25
KR20090057296A (ko) 2009-06-04
IL197220A0 (en) 2009-12-24
ES2755386T5 (es) 2023-04-05
EA200970231A1 (ru) 2009-08-28
US8513393B2 (en) 2013-08-20
PL2061803T5 (pl) 2023-03-27
ES2755386T3 (es) 2020-04-22
PT2061803T (pt) 2019-11-21
EP2061803B1 (en) 2019-08-14
MX2009002014A (es) 2009-03-09
IL197220A (en) 2013-06-27
CA2661748C (en) 2016-02-09
AR062570A1 (es) 2008-11-19
WO2008025748A1 (en) 2008-03-06
UA99262C2 (uk) 2012-08-10
EP2061803B2 (en) 2022-11-16
SI2061803T1 (sl) 2019-12-31
AU2007291283A1 (en) 2008-03-06
DK2061803T4 (da) 2022-12-05

Similar Documents

Publication Publication Date Title
HK1131400A1 (en) Process for the purification of fc-containing proteins
IL199753A0 (en) Process for the purification of fc-containing proteins
ZA200900836B (en) Process for the purification of FC-fusion proteins
EP2054521A4 (en) METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
EP2226331A4 (en) METHOD OF PURIFYING PROTEINS
IL205107A0 (en) Method for purifying fc-fusion proteins
ZA200708526B (en) Process for the removal of contaminants
IL184184A0 (en) Process for the purification of duloxetine hydrochloride
HUE042402T2 (hu) Eljárás polipeptid töményítésére
IL204949A0 (en) Method for purifying an fc- containing protein
EP1960416A4 (en) PROCESS FOR PURIFYING CHENODESOXYCHOLIC ACID
EP1869230A4 (en) PROCESS FOR PURIFYING PROTEINS
ZA200607439B (en) Process for gas purification
GB0503942D0 (en) Purification process
ZA200900837B (en) Process for the purification of FC-containing proteins
IL184715A0 (en) Process for the preparation of intermediates
PL1973563T3 (pl) Sposób oczyszczania alfa-1-antytrypsyny
GB0624227D0 (en) Protein purification
EP1899375A4 (en) NEW METHOD FOR THE PURIFICATION OF LACTOFERRIN
GB0523257D0 (en) Purification process
SI1966228T1 (sl) Postopek čiščenja za henodeoksiholinsko kislino
ZA200708802B (en) An improved process for the purification of perindopril
HK1137378A1 (en) Process for the purification of combustion fumes
PL2079758T3 (pl) Sposób oczyszczania DnaK
PL380473A1 (pl) Sposób wytwarzania modyfikowanego kaolinu